CORCencora
Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. 10-K, Item 1
- Employees
- 51,000
- Headquarters
- Conshohocken, PA
- CEO
- Robert P. Mauch
- Next results
- around Feb 3, 2027
Every trade in COR shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.
| Date | Insider | Role | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Lazarus Krikorian | SVP & Chief Accounting Officer | Sale (10b5-1) | -986 | 330.96 | 326K | 14,197 |
| Oct 1, 2026 | Lazarus Krikorian | SVP & Chief Accounting Officer | Sale (10b5-1) | -986 | 303.18 | 299K | 15,183 |
| Sep 16, 2026 | Lon R. Greenberg | Director | Sale | -1,280 | 321.30 | 411K | 17,128 |
| Sep 1, 2026 | Lazarus Krikorian | SVP & Chief Accounting Officer | Sale (10b5-1) | -985 | 325.97 | 321K | 16,169 |
| Aug 24, 2026 | Elizabeth S. Campbell | Executive Vice President | Sale | -11,300 | 324.12 | 3.7M | 19,455 |
| Jun 22, 2026 | Lauren M. Tyler | Director | Buy | 550 | 270.23 | 149K | 4,359 |
| Jun 18, 2026 | Dermot Mark Durcan | Director | Buy | 4,000 | 274.19 | 1.1M | 31,767 |
| May 28, 2026 | Dermot Mark Durcan | Director | Buy | 4,000 | 266.26 | 1.1M | 27,767 |
From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).
Work on COR in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/COR/export.csv") into a cell.